Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp) is a research paper published in Contemporary Clinical Trials Communications (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Nursing Research
Grant: K23NR018482
National Institute of Nursing Research
Grant: L30NR020114
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: U01DK123787
National Center for Complementary and Integrative Health
Grant: K24AT011995
National Institutes of Health
Grant: 3U01DK123787-01S1
University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical Center
National Institutes of Health
Grant: 1K23NR018482-01A1
Changes in Oral and Gut Microbiota and Incidence and Severity of Patient-Reported Symptoms in Pre- and Post-Kidney Transplant Patients
National Institutes of Health
Grant: 1K24AT011995-01
Providing training in effective non-opioid options for the treatment of pain conditions.
U.S. Department of Veterans Affairs
National Institutes of Health
U.S. Department of Health and Human Services
Fields of Study
Keywords
Sustainable Development Goals